Through the looking glass: understanding non-inferiority

被引:314
作者
Schumi, Jennifer [1 ]
Wittes, Janet T. [1 ]
机构
[1] Stat Collaborat Inc, Washington, DC 20036 USA
来源
TRIALS | 2011年 / 12卷
关键词
PLACEBO-CONTROLLED TRIALS; ACTIVE-CONTROL TRIALS; RANDOMIZED TRIALS; ISSUES; NONINFERIORITY;
D O I
10.1186/1745-6215-12-106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration.
引用
收藏
页数:12
相关论文
共 18 条
  • [1] [Anonymous], 2000, METAANALYSIS DECISIO
  • [2] [Anonymous], 2010, Guidance for industry non-inferiority clinical trials
  • [3] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [4] Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases
    Ellenberg, SS
    Temple, R
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 464 - 470
  • [5] EMA CPMP, 2000, POINTS CONS SWITCH S
  • [6] EMA-CHMP, 2005, GUID CHOIC NON MARG
  • [7] Issues in Noninferiority Trials: The Evidence in Community-Acquired Pneumonia
    Fleming, Thomas R.
    Powers, John H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 : S108 - S120
  • [8] Current issues in non-inferiority trials
    Flerning, Thomas R.
    [J]. STATISTICS IN MEDICINE, 2008, 27 (03) : 317 - 332
  • [9] MANTEL N, 1959, JNCI-J NATL CANCER I, V22, P719
  • [10] Design and analysis of non-inferiority mortality trials in oncology
    Rothmann, M
    Li, N
    Chen, G
    Chi, GYH
    Temple, R
    Tsou, HH
    [J]. STATISTICS IN MEDICINE, 2003, 22 (02) : 239 - 264